Memorial Sloan Kettering Cancer Center (MSK) Shares Positive Preliminary Results of Flibanserin in Breast Cancer Patients Suffering from Low Libido - PR Newswire

/PRNewswire/ -- New research from Memorial Sloan Kettering Cancer Center (MSK) led by medical oncologist Shari Goldfarb, MD, and colleagues, reports positive...

Dr. Shari Goldfarb, a breast medical oncologist from Memorial Sloan Kettering Cancer Center and the study's primary investigator said, "Sexual dysfunction is one of the most common and unaddressed si… [+12228 chars]

full article...